Details for Patent: 10,888,516
✉ Email this page to a colleague
Which drugs does patent 10,888,516 protect, and when does it expire?
Patent 10,888,516 protects IMVEXXY and is included in one NDA.
This patent has one hundred and sixty-two patent family members in twenty-one countries.
Summary for Patent: 10,888,516
Title: | Soluble estradiol capsule for vaginal insertion |
Abstract: | According to various embodiments of this disclosure, pharmaceutical formulations comprising solubilized estradiol are provided. In various embodiments, such formulations are encapsulated in soft capsules which may be vaginally inserted for the treatment of vulvovaginal atrophy. |
Inventor(s): | Bernick; Brian A. (Boca Raton, FL), Amadio; Julia M. (Boca Raton, FL), Persicaner; Peter H. R. (Boca Raton, FL), Thorsteinsson; Thorsteinn (Boynton Beach, FL), Cacace; Janice Louise (St. Petersburg, FL), Sancilio; Frederick D. (Stuart, FL), Irani; Neda (Palm Beach Gardens, FL) |
Assignee: | TherapeuticsMD, Inc. (Boca Raton, FL) |
Application Number: | 16/833,213 |
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 10,888,516
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mayne Pharma | IMVEXXY | estradiol | INSERT;VAGINAL | 208564-001 | May 29, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF DYSPAREUNIA | ⤷ Sign Up | ||||
Mayne Pharma | IMVEXXY | estradiol | INSERT;VAGINAL | 208564-001 | May 29, 2018 | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF A SYMPTOM OF VULVAR AND VAGINAL ATROPHY | ⤷ Sign Up | ||||
Mayne Pharma | IMVEXXY | estradiol | INSERT;VAGINAL | 208564-002 | May 29, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF DYSPAREUNIA | ⤷ Sign Up | ||||
Mayne Pharma | IMVEXXY | estradiol | INSERT;VAGINAL | 208564-002 | May 29, 2018 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | TREATMENT OF A SYMPTOM OF VULVAR AND VAGINAL ATROPHY | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,888,516
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2782584 | ⤷ Sign Up | 301153 | Netherlands | ⤷ Sign Up |
European Patent Office | 2782584 | ⤷ Sign Up | 2021C/558 | Belgium | ⤷ Sign Up |
European Patent Office | 2782584 | ⤷ Sign Up | 122021000080 | Germany | ⤷ Sign Up |
European Patent Office | 2782584 | ⤷ Sign Up | LUC00245 | Luxembourg | ⤷ Sign Up |
European Patent Office | 2782584 | ⤷ Sign Up | 132021000000197 | Italy | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |